Moody National Bank Trust Division lifted its position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 29.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 81,551 shares of the company’s stock after purchasing an additional 18,607 shares during the quarter. Moody National Bank Trust Division owned 0.06% of AdaptHealth worth $816,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its position in AdaptHealth by 197.1% in the 1st quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock valued at $29,000 after buying an additional 1,683 shares during the last quarter. Covestor Ltd lifted its stake in AdaptHealth by 279.6% in the 1st quarter. Covestor Ltd now owns 3,109 shares of the company’s stock valued at $36,000 after purchasing an additional 2,290 shares during the last quarter. Beacon Investment Advisory Services Inc. acquired a new position in shares of AdaptHealth during the first quarter worth $118,000. SG Americas Securities LLC acquired a new position in shares of AdaptHealth in the 1st quarter valued at about $129,000. Finally, LRI Investments LLC acquired a new stake in AdaptHealth in the first quarter valued at approximately $135,000. Institutional investors own 82.67% of the company’s stock.
AdaptHealth Stock Down 0.3 %
Shares of AHCO stock traded down $0.03 during mid-day trading on Monday, hitting $10.97. 1,763,172 shares of the stock traded hands, compared to its average volume of 1,042,533. The stock’s fifty day moving average is $10.58 and its two-hundred day moving average is $9.77. The stock has a market cap of $1.46 billion, a P/E ratio of -2.06, a P/E/G ratio of 0.76 and a beta of 1.10. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.33 and a quick ratio of 1.11. AdaptHealth Corp. has a 52-week low of $6.37 and a 52-week high of $15.37.
Analysts Set New Price Targets
Separately, Truist Financial restated a “buy” rating and set a $13.00 price target on shares of AdaptHealth in a research note on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $10.70.
Read Our Latest Stock Analysis on AHCO
AdaptHealth Profile
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
See Also
- Five stocks we like better than AdaptHealth
- Why is the Ex-Dividend Date Significant to Investors?
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- What is a Special Dividend?
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.